Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Feb 17, 2015 · 10-Q · 48 days after period end · 0001144204-15-009533
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$345.48K | $26.40K | -$387.75K | -$2.71M |
| EPS Diluted | $0.00 | $0.00 | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Feb 17, 2015 · 48 d after period end
